Product Categories
Country: | China |
---|---|
Tel: | 020-82000279 |
Mobile: | 18024082417 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
SB-209670 | C29H28O9 | 157659-79-5 | Details |
SR121566A | C20H25N5O4S | 180144-61-0 | Details |
BILB-1941 | C34H34N4O4 | 494856-61-0 | Details |
GW-493838 | C21H21ClFN7O4 | 253124-46-8 | Details |
PF-06795071 | C18H17F4N3O3 | 2075629-81-9 | Details |
TFAX 488,TFP | C33H29F4N3O11S2 | 878546-79-3 | Details |
MK-6240 Precursor | C26 H27 N5 O6 | 1841444-11-8 | Details |
17-DMAP-GA | C33H50N4O8 | 169521-68-0 | Details |
ERRγ Inverse Agonist 1 | C30H37ClN2O2 | 2316832-86-5 | Details |
6-trans-12-epi-Leukotriene B4 | C20H32O4 | 71548-19-1 | Details |
NCOA4 - 9a | C27H28FN5 | 2650557-72-3 | Details |
1,1-Dibromo-3-chloroacetone | C3H3Br2ClO | 1578-18-3 | Details |
ML-9 Free Base | C15H17ClN2O2S | 110448-31-2 | Details |
Atorvastatin lactone D5 | C33H33FN2O4 | 1217749-86-4 | Details |
SL910102 | C30H30N6O | 144756-71-8 | Details |
Adenosine 5'-succinate | C14H17N5O7 | 102029-71-0 | Details |
Phthalimide-PEG3-C2-OTs | C23H27NO8S | 382162-12-1 | Details |
Daclatasvir Impurity C | C29H32N6O3 | 1256385-55-3 | Details |
LY3020371 | C15H15F2NO5S | 1377615-75-2 | Details |
1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-cyclopropylurea | C22H23N5O2S | 1144075-40-0 | Details |
MK-447 | C11H16INO | 58456-91-0 | Details |
5,6-Dichlorovanillin | C8H6Cl2O3 | 18268-69-4 | Details |
CGP-53153 | C23H33N3O2 | 149281-19-6 | Details |
1,3-Dibromo-1,3-dichloroacetone | C3H2Br2Cl2O | 62874-84-4 | Details |
Thiamine diphosphate analog 1 | C6H11NO7P2S | 2606-90-8 | Details |
JMS-17-2 hydrochloride | C25H27Cl2N3O | 2341841-07-2 | Details |
(-)-SHIN1 | C24H24N4O2 | 2444764-09-2 | Details |
Aβ42-IN-1 free base | C29H26N4O2 | 2434633-17-5 | Details |
Mukanadin C | C7H7BrN2O2 | 1839104-78-7 | Details |
UCB-J | C17H15F3N2O | 2242957-52-2 | Details |
Timobesone | C22H29FO4S | 87116-72-1 | Details |
DOTA derivative | C43H50N4O8S4 | 153777-70-9 | Details |
Urinary Incontinence-Targeting Compound 1 | C9H13FN2O3S | 137315-05-0 | Details |
Rocagloic acid | C27H26O8 | 190385-15-0 | Details |
Dox-Ph-PEG1-Cl | C11H13ClO3 | 773095-86-6 | Details |
N-acetyl Dapsone (D4') | C14H14N2O3S | 2070015-28-8 | Details |
Kgp-IN-1 hydrochloride | C19H25ClF4N4O3 | 2097865-47-7 | Details |
TV 3279 | C16H20N2O2 | 209394-29-6 | Details |
Diarylalkane derivative 1 | C34H51NO4 | 191155-65-4 | Details |
chaetoglobosin Vb | C32H36N2O5 | 1399690-75-5 | Details |
Prinomide tromethamine | C15H13N3O2.C4H11NO3 | 109636-76-2 | Details |
PD-1/PD-L1-IN 5 TFA | C24H19F3N4O5S | 2170209-52-4 | Details |
Hepatitis Virus C NS3 Protease Inhibitor 2 | C43H56N6O14S | 208939-95-1 | Details |
19-Heptatriacontanol | C37H76O | 872307-34-1 | Details |
Tebufelone | C20H28O2 | 112018-00-5 | Details |
Orotidine 5′-monophosphate | C10H13N2O11P | 2149-82-8 | Details |
PI5P4Ks-IN-2 | C22H23N5 | 2766854-03-7 | Details |
Maltoheptaose hydrate | C42H74O37 | 331748-09-5 | Details |
O-Methylpodocarpic acid | C18H24O3 | 10037-26-0 | Details |
LH secretion antagonist 1 | C18H24ClNO2 | 88531-67-3 | Details |
7-Oxotridecanedioic acid | C13H22O5 | 101171-43-1 | Details |
BI-1230 | C42H52N6O9S | 849022-32-8 | Details |
(R,1R)-Tenofovir amibufenamide | C22H31N6O5P | 1571076-37-3 | Details |
(S,R,S)-AHPC-Me-C10-NH2 hydrochloride | C34H54ClN5O4S | 2471970-07-5 | Details |
2H-Pyrido[2',1':3,4]pyrazino[1,2-b]indazole-3-carboxylic acid, 6-(1,1-dimethylethyl)-6,7-dihydro-10-(3-methoxypropoxy)-2-oxo-, (6R)- | C23H27N3O5 | 2247932-38-1 | Details |
3,4,5-Trichlorosyringol | C8H7Cl3O3 | 2539-26-6 | Details |
Microcolin B | C39H65N5O8 | 141205-32-5 | Details |
Chitohexaose hexahydrochloride | C36H69ClN6O25 | 127171-88-4 | Details |
N-(Biotin-PEG4)-N-bis(PEG4-acid) | C42H78N4O18S | 2112731-48-1 | Details |
DBCO-C2-SulfoNHS ester | C23H18N2O8S | 1803279-86-8 | Details |
17-GMB-APA-GA | C39H53N5O11 | 256337-10-7 | Details |
WCK-5153 | 1436862-38-2 | Details |
SW209049 | C25H18N2O4S | 1673558-59-2 | Details |
Seclazone | C10H8ClNO3 | 29050-11-1 | Details |
(R)-Plevitrexed | C26H25FN8O4 | 153537-74-7 | Details |
4-Aza-Oleanolic acid methyl ester | C28H43NO3 | 557766-15-1 | Details |
Elacestrant S enantiomer dihydrochloride | C30H39ClN2O2 | 2309762-30-7 | Details |
Ilmetropium iodide | C20H30INO3 | 129109-88-2 | Details |
9,10-Dichlorostearic acid | C18H34Cl2O2 | 5829-48-1 | Details |
CHMFL-KIT-033 | C23H18FN5O2 | 2351801-41-5 | Details |
Aeruginosin 865 | C41H64N6O14 | 1611990-01-2 | Details |
TRC-766 | C25 H24 Cl F3 N2 O3 S | 1810734-44-1 | Details |
T3-ATA (S-isomer) | C19H16I3NO6S | 2438721-48-1 | Details |
Eptifibatide acetate | 1248559-53-6 | Details |
Bimosiamose disodium | C46H52Na2O16 | 187269-60-9 | Details |
JTK-109 | C37H33ClFN3O4 | 480462-62-2 | Details |
LY-402913 | C28H24ClN3O6 | 334970-65-9 | Details |
HKOCl-4 | C38H35Cl2NO7 | 2031170-85-9 | Details |
T4-ATA (S-isomer) | C19H15I4NO6S | 2448470-97-9 | Details |
A3334 | C17H13N3O3 | 854171-31-6 | Details |
Soluplus | 402932-23-4 | Details |
PYBG-BODIPY | C38H39BF2N10O3 | 2068027-79-0 | Details |
RDR03871 | C18H16ClF3N6 | 286008-51-3 | Details |
Usmarapride | C23H31N5O6 | 1428862-33-2 | Details |
Lesopitron | C15H21ClN6 | 132449-46-8 | Details |
Erythromycin ethylsuccinate- | C23H25ClF2N4OS | 2375781-06-7 | Details |
1-(2-fluoroethyl)-3-{4-[4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)thieno[3,2-d]pyrimidin-2-yl]phenyl}urea | C21H22FN5O2S | 1144075-36-4 | Details |
1,2-diphenylpropan-2-amine | C15H17N | 118910-28-4 | Details |
Opaviraline | C14H17FN2O3 | 178040-94-3 | Details |
FR167344 free base | C30H28BrCl2N5O4 | 215258-13-2 | Details |
ML786 dihydrochloride | C29H30ClF3N4O3 | 1237536-18-3 | Details |
Chitoheptaose heptahydrochloride | C42H80ClN7O29 | 127171-89-5 | Details |
MK-8325 dihydrochloride | C43H53ClF2N8O6Si | 1334314-19-0 | Details |
Glycosidase-IN-1 | C13H23NO5 | 170376-12-2 | Details |
RIP2 kinase inhibitor 1 | C17H17N5O2S | 2380028-10-2 | Details |
NH2-C2-amido-C2-Boc | C10H20N2O3 | 1692613-62-9 | Details |
Neurodegenerative Disorder-Targeting Compound 1 | C28H28N4O4 | 1254698-39-9 | Details |
Cys modifier 1 | C18H15N5O5 | 2374314-08-4 | Details |
H-Asn-Arg-OH | C10H20N6O4 | 2478-01-5 | Details |
NPEC-caged-LY379268 | C16H16N2O9 | 1315379-62-4 | Details |
Product Total: Product Page: | ||||
74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 |